Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma
Phosphatidylinositol 3-kinase, Akt, and the mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway is shown to play a key role in the tumorigenesis, proliferation, metastasis, apoptosis, and angiogenesis of hepatocellular carcinoma (HCC) by regulating gene expression. The components and fun...
Main Author: | |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2014-09-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=6022&ClassID=86133911 |
id |
doaj-daa30aedfc9a4e9889913c2ca1598161 |
---|---|
record_format |
Article |
spelling |
doaj-daa30aedfc9a4e9889913c2ca15981612020-11-24T21:35:07ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562014-09-0130995495710.3969/j.issn.1001-5256.2014.09.029Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinomaYU Yuan0Department of Traditional Chinese Medicine, Shanghai Public Health Clinical Center, Public Health Clinical Center Affiliated to Fudan University, Shanghai 201508, ChinaPhosphatidylinositol 3-kinase, Akt, and the mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway is shown to play a key role in the tumorigenesis, proliferation, metastasis, apoptosis, and angiogenesis of hepatocellular carcinoma (HCC) by regulating gene expression. The components and functions of PI3K/Akt/mTOR signaling pathway are briefly described, and the research advances in the action mechanism of PI3K/Akt/mTOR signaling pathway in the progression of HCC and related inhibitors are reviewed. It is disclosed that blocking the PI3K/Akt/mTOR signaling pathway may become a new therapy for HCC.http://www.lcgdbzz.org/qk_content.asp?id=6022&ClassID=86133911hepatocellular carcinoma; adaptor proteinssignal transducing; revie |
collection |
DOAJ |
language |
zho |
format |
Article |
sources |
DOAJ |
author |
YU Yuan |
spellingShingle |
YU Yuan Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma Linchuang Gandanbing Zazhi hepatocellular carcinoma; adaptor proteins signal transducing; revie |
author_facet |
YU Yuan |
author_sort |
YU Yuan |
title |
Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma |
title_short |
Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma |
title_full |
Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma |
title_fullStr |
Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma |
title_full_unstemmed |
Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma |
title_sort |
role of pi3k/akt/mtor signaling pathway in hepatocellular carcinoma |
publisher |
Editorial Department of Journal of Clinical Hepatology |
series |
Linchuang Gandanbing Zazhi |
issn |
1001-5256 1001-5256 |
publishDate |
2014-09-01 |
description |
Phosphatidylinositol 3-kinase, Akt, and the mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway is shown to play a key role in the tumorigenesis, proliferation, metastasis, apoptosis, and angiogenesis of hepatocellular carcinoma (HCC) by regulating gene expression. The components and functions of PI3K/Akt/mTOR signaling pathway are briefly described, and the research advances in the action mechanism of PI3K/Akt/mTOR signaling pathway in the progression of HCC and related inhibitors are reviewed. It is disclosed that blocking the PI3K/Akt/mTOR signaling pathway may become a new therapy for HCC. |
topic |
hepatocellular carcinoma; adaptor proteins signal transducing; revie |
url |
http://www.lcgdbzz.org/qk_content.asp?id=6022&ClassID=86133911 |
work_keys_str_mv |
AT yuyuan roleofpi3kaktmtorsignalingpathwayinhepatocellularcarcinoma |
_version_ |
1725946523939766272 |